{"id":47459,"date":"2022-08-18T22:01:40","date_gmt":"2022-08-18T20:01:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/"},"modified":"2022-08-18T22:01:40","modified_gmt":"2022-08-18T20:01:40","slug":"medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/","title":{"rendered":"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities"},"content":{"rendered":"
\n

\nTop connectivity services company will leverage Lyniate EMPI solution to strengthen the accuracy of the data it exchanges to better serve its clients and partners<\/i>\n<\/p>\n

BOSTON–(BUSINESS WIRE)–Lyniate<\/a>, <\/b>a global leader in healthcare data interoperability, today announced MedAllies<\/a>, a leading multimodality connectivity services company, has chosen Lyniate Enterprise Master Patient Index (EMPI) by NextGate<\/a> to better serve its healthcare clients and partners. This integration will bolster MedAllies\u2019 identity data management capabilities to increase the accuracy of the data it exchanges for the benefit of all.\n<\/p>\n

<\/a><\/p>\n

\nAs the healthcare industry continues to shift toward a more consumer-centric approach to interoperability, MedAllies maintains its commitment to providing connectivity services to thousands of healthcare providers and organizations across the country. The company turned to Lyniate for its proven identity management solutions and unparalleled approach to facilitating real-time data exchange.\n<\/p>\n

\n\u201cMedAllies realized the pressing need to invest in EMPI technology, and we are excited to partner and provide solutions that will strengthen the company\u2019s data exchange services,\u201d said Scott Galbari, president and COO of Lyniate. \u201cMedAllies understands the need to ensure the data it helps customers exchange is accurate so as not to negatively impact care, and recognizes that more accurate data can better support MedAllies\u2019 own strategic initiatives. We applaud MedAllies for prioritizing this investment and having the vision to bring this crucial capability to its customers.\u201d\n<\/p>\n

\nLyniate EMPI has the flexibility to support on-premises and cloud deployments with the ability to adapt and scale over time. It offers options for resolution of data issues using referential data as well as manual data remediation. Beyond its proven technology, Lyniate offers a world-class, hands-on approach to customer support and training to ensure its clients maximize their investment in patient data accuracy.\n<\/p>\n

\n\u201cOur clients and partners have spoken clearly: They need identity data solutions to be confident in the accuracy of the data that powers their businesses,\u201d said Tom Visotsky, chief commercial officer at MedAllies. \u201cAfter a great deal of due diligence, we came to the conclusion that Lyniate offers the most mature and robust EMPI solution on the market. We are excited to bring this powerful capability to meet our clients\u2019 needs, fortify our care quality offering, and help our partners to thrive in a data-driven and consumer-focused healthcare environment.\u201d\n<\/p>\n

\nTo learn more, please visit Lyniate in booth #22 at the Civitas Conference<\/a> August 21-24 in San Antonio, Texas.\n<\/p>\n

\nAbout Lyniate:
\n
<\/b>Lyniate partners with healthcare organizations around the globe delivering a flexible interoperability suite that reliably connects people and the quality data they need. As a trusted partner, Lyniate powers the applications and workflows that improve clinical, operational, and financial outcomes today while helping healthcare teams to understand, prepare for, and influence changes on the horizon. Lyniate is committed to empowering people with Best-in-KLAS\u00ae ranking interoperability solutions for healthcare, from specialty clinics to large care networks, from health insurance providers to health technology, and everything in between. Visit https:\/\/lyniate.com<\/a> to connect.\n<\/p>\n

\nAbout MedAllies:
\n
<\/b>MedAllies securely delivers vital health information to impact care by operating multiple national networks supporting interoperability for all healthcare constituents. We are focused on network and service excellence for individuals, connections, and participants accessing our Connectivity Services. We serve more than 700 hospitals, 5,000 organizations, 100,000 providers, and dozens of partners bringing together millions for a more fluid healthcare experience. To learn more, visit http:\/\/www.MedAllies.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:
\n
<\/b>Jennifer Brooks
\n
Aria Marketing for Lyniate
\n
(479) 426-6855
\n
jbrooks@ariamarketing.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Top connectivity services company will leverage Lyniate EMPI solution to strengthen the accuracy of the data it exchanges to better serve its clients and partners BOSTON–(BUSINESS WIRE)–Lyniate, a global leader in healthcare data interoperability, today announced MedAllies, a leading multimodality connectivity services company, has chosen Lyniate Enterprise Master Patient Index (EMPI) by NextGate to better … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-47459","format-standard","category-industry"],"yoast_head":"\nMedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Top connectivity services company will leverage Lyniate EMPI solution to strengthen the accuracy of the data it exchanges to better serve its clients and partners BOSTON–(BUSINESS WIRE)–Lyniate, a global leader in healthcare data interoperability, today announced MedAllies, a leading multimodality connectivity services company, has chosen Lyniate Enterprise Master Patient Index (EMPI) by NextGate to better ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-18T20:01:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220818005731\/en\/1548361\/21\/Lyniate_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities\",\"datePublished\":\"2022-08-18T20:01:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/\"},\"wordCount\":578,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005731\\\/en\\\/1548361\\\/21\\\/Lyniate_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/\",\"name\":\"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005731\\\/en\\\/1548361\\\/21\\\/Lyniate_Logo.jpg\",\"datePublished\":\"2022-08-18T20:01:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005731\\\/en\\\/1548361\\\/21\\\/Lyniate_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005731\\\/en\\\/1548361\\\/21\\\/Lyniate_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/","og_locale":"en_US","og_type":"article","og_title":"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities - Pharma Trend","og_description":"Top connectivity services company will leverage Lyniate EMPI solution to strengthen the accuracy of the data it exchanges to better serve its clients and partners BOSTON–(BUSINESS WIRE)–Lyniate, a global leader in healthcare data interoperability, today announced MedAllies, a leading multimodality connectivity services company, has chosen Lyniate Enterprise Master Patient Index (EMPI) by NextGate to better ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-18T20:01:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220818005731\/en\/1548361\/21\/Lyniate_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities","datePublished":"2022-08-18T20:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/"},"wordCount":578,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220818005731\/en\/1548361\/21\/Lyniate_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/","url":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/","name":"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220818005731\/en\/1548361\/21\/Lyniate_Logo.jpg","datePublished":"2022-08-18T20:01:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220818005731\/en\/1548361\/21\/Lyniate_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220818005731\/en\/1548361\/21\/Lyniate_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/medallies-selects-lyniate-for-enhanced-identity-data-management-capabilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47459"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47459\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}